The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Commerce and Industry Minister Piyush Goyal will travel to Muscat, Oman, starting Monday to give "further impetus" to the free trade agreement (FTA) talks between India and Oman. “The talks on the ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

A first-ever taxi service operating on hydrogen-powered cars will be launched in the Sultanate of Oman during the current year, the Minister of Transport, Communications and Information Technology, ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Under the auspices of His Highness Sayyid Marwan bin Turki al Said, Governor of Dhofar, Oman Design Week (ODW) officially began at the Al Irfan Boulevard Garden in the Oman Convention and Exhibition ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Oman has announced a public holiday on Thursday, January 30, 2025, to mark Isra Wal Miraj. The holiday will apply to employees across both public and private sectors, according to a statement from ...